{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:55:54Z","timestamp":1772754954053,"version":"3.50.1"},"reference-count":43,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2023,7,31]]},"DOI":"10.7883\/yoken.jjid.2022.470","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T22:25:46Z","timestamp":1680215146000},"page":"226-232","source":"Crossref","is-referenced-by-count":2,"title":["Can Fractional Exhaled Nitric Oxide (FeNO) Serve as a Clinical Indicator for Patients Hospitalized with Crimean-Congo Hemorrhagic Fever?"],"prefix":"10.7883","volume":"76","author":[{"given":"Ferhan","family":"Kerget","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Erzurum Regional Training and Research Hospital, University of Health Sciences, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bu\u011fra","family":"Kerget","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Diseases, Faculty of Medicine, Ataturk University, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Karti SS, Odabasi Z, Korten V, et al. Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis. 2004;10:1379-1384.","DOI":"10.3201\/eid1008.030928"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Leblebicioglu H, Ozaras R, Fletcher TE, et al. ESCMID Study Group for Infections in Travellers and Migrants (ESGITM). Crimean-Congo haemorrhagic fever in travellers: A systematic review Travel Med Infect Dis. 2016;14:73-80.","DOI":"10.1016\/j.tmaid.2016.03.002"},{"key":"3","unstructured":"3. Burt FJ, Swanepoel R, Shieh WJ, et al. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch Pathol Lab Med. 1997;121:839-846."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ergonul O. Crimean-Congo hemorrhagic fever virus: new outbreaks, new discoveries. Curr Opin Virol. 2012;2:215-220.","DOI":"10.1016\/j.coviro.2012.03.001"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Davies MG, Hagen PO. Systemic inflammatory response syndrome. Br J Surg. 1997;84:920-935.","DOI":"10.1002\/bjs.1800840707"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Bodur H, Ak\u0131nc\u0131 E, \u00d6ng\u00fcr\u00fc P, et al. Evidence of vascular endothelial damage in Crimean-Congo hemorrhagic fever. Int J Infect Dis. 2010;14:e704-e707.","DOI":"10.1016\/j.ijid.2010.02.2240"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Reiss CS, Komatsu T. Does nitric oxide play a critical role in viral infections? J Virol. 1998;72:4547-4551.","DOI":"10.1128\/JVI.72.6.4547-4551.1998"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Uehara EU, Shida BdS, de Brito CA. Role of nitric oxide in immune responses against viruses: beyond microbicidal activity. Inflamm Res. 2015;64:845-852.","DOI":"10.1007\/s00011-015-0857-2"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kerget B, Araz \u00d6, Akg\u00fcn M. The role of exhaled nitric oxide (FeNO) in the evaluation of lung parenchymal involvement in COVID-19 patients. Intern Emerg Med. 2022;17:1951-1958.","DOI":"10.1007\/s11739-022-03035-4"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Rivero A. Nitric oxide: an antiparasitic molecule of invertebrates. Trends Parasitol. 2006;22:219-225.","DOI":"10.1016\/j.pt.2006.02.014"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ricciardolo FLM, Sterk PJ, Gaston B, et al. Nitric oxide in health and disease of the respiratory system. Physiol Rev. 2004;84:731-765.","DOI":"10.1152\/physrev.00034.2003"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002-2012.","DOI":"10.1056\/NEJM199312303292706"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Sugiura H, Ichinose M. Nitrative stress in inflammatory lung diseases. Nitric Oxide. 2011;25:138-144.","DOI":"10.1016\/j.niox.2011.03.079"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ricciardolo FLM, Nijkamp FP, Folkerts G. Nitric oxide synthase (NOS) as therapeutic target for asthma and chronic obstructive pulmonary disease. Curr Drug Targets. 2006;7:721-735.","DOI":"10.2174\/138945006777435290"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. T\u00fct\u00fcnc\u00fc EE, Gurbuz Y, Ozturk B, et al. Serum nitric oxide levels in patients with Crimean-Congo haemorrhagic fever. Scand J Infect Dis. 2010;42:385-388.","DOI":"10.3109\/00365540903501624"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Simon M, Falk KI, Lundkvist \u00c5, et al. Exogenous nitric oxide inhibits Crimean Congo hemorrhagic fever virus. Virus Res. 2006;120:184-190.","DOI":"10.1016\/j.virusres.2006.03.005"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184:602-615.","DOI":"10.1164\/rccm.9120-11ST"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Erg\u00f6n\u00fcl \u00d6, \u015eeref C, Eren \u015e, et al. Cytokine response in Crimean\u2010Congo hemorrhagic fever virus infection. J Med Virol. 2017;89:1707-1713.","DOI":"10.1002\/jmv.24864"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Swanepoel R, Gill DE, Shepherd AJ, et al. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis. 1989;11:S794-S800.","DOI":"10.1093\/clinids\/11.Supplement_4.S794"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Burt FJ, Leman PA, Smith JF, et al. The use of a reverse transcription\u2013polymerase chain reaction for the detection of viral nucleic acid in the diagnosis of Crimean-Congo haemorrhagic fever. J Virol Methods. 1998;70:129-137.","DOI":"10.1016\/S0166-0934(97)00182-1"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kerget F, \u00d6zkurt Z, \u00d6zt\u00fcrk N, et al. The relationship with clinical course and prognosis of serum endothelin-1, angiopoietin-2, and tie-2 levels in Crimean-Congo hemorrhagic fever. Turk J Med Sci. 2019;49:1192-1197.","DOI":"10.3906\/sag-1812-10"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Erg\u00f6n\u00fcl \u00d6, \u00c7elikba\u015f A, Dokuzo\u011fuz B, et al. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin Infect Dis. 2004;39:284-287.","DOI":"10.1086\/422000"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Erg\u00f6n\u00fcl \u00d6. Crimean-Congo haemorrhagic fever: Treatment and use of ribavirin. Klimik Dergisi. 2016;29:2-9. Available at <https:\/\/www.klimikdergisi.org\/wp-content\/uploads\/2021\/01\/kirim-kongo-kanamali-atesi-tedavisi-ve-ribavirin-kullanimi.pdf>. Turkish.","DOI":"10.5152\/kd.2016.02"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ak\u0131nc\u0131 E, Bodur H, Leblebicioglu H. Pathogenesis of Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis. 2013;13:429-437.","DOI":"10.1089\/vbz.2012.1061"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kerget F, Demird\u00f6\u011fen \u015eO, Kerget B. Case report: A rare case of Crimean-Congo hemorrhagic fever associated with epididymo-orchitis. Am J Trop Med Hyg. 2021;104:1055-1057.","DOI":"10.4269\/ajtmh.20-1143"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Trindade MC, Lind M, Nakashima Y, et al. Interleukin-10 inhibits polymethylmethacrylate particle induced interleukin-6 and tumor necrosis factor-\u03b1 release by human monocyte\/macrophages in vitro. Biomaterials. 2001;22:2067-2073.","DOI":"10.1016\/S0142-9612(00)00376-8"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Shahhosseini N, Wong G, Babuadze G, et al. Crimean-Congo hemorrhagic fever virus in Asia, Africa and Europe. Microorganisms. 2021;9:1907.","DOI":"10.3390\/microorganisms9091907"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Ergonul O, Tuncbilek S, Baykam N, et al. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-\u03b1 in patients with Crimean-Congo hemorrhagic fever. J Infect Dis. 2006;193:941-944.","DOI":"10.1086\/500836"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Toda N, Nakanishi-Toda M. How mental stress affects endothelial function. Pflugers Arch. 2011;462:779-794.","DOI":"10.1007\/s00424-011-1022-6"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. De Caterina R, Libby P, Peng HB, et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest. 1995;96:60-68.","DOI":"10.1172\/JCI118074"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Fischer A, Folkerts G, Geppetti P, et al. Mediators of asthma: nitric oxide. Pulm Pharmacol Ther. 2002;15:73-81.","DOI":"10.1006\/pupt.2001.0332"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Vodenicharov A. Structure and function of smooth muscle with special reference to mast cells. In: Sugi H, editor. Current Basic and Pathological Approaches to the Function of Muscle Cells and Tissues \u2013 From Molecules to Humans. IntechOpen; 2012. p346-362.","DOI":"10.5772\/48566"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Gao PS, Kawada H, Kasamatsu T, et al. Variants of NOS1, NOS2, and NOS3 genes in asthmatics. Biochem Biophys Res Commun. 2000;267:761-763.","DOI":"10.1006\/bbrc.1999.2030"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Pijnenburg MW. The role of FeNO in predicting asthma. Front Pediatr. 2019;7:41.","DOI":"10.3389\/fped.2019.00041"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Dahgam S, Nyberg F, Modig L, et al. Single nucleotide polymorphisms in the NOS2 and NOS3 genes are associated with exhaled nitric oxide. J Med Genet. 2012;49:200-205.","DOI":"10.1136\/jmedgenet-2011-100584"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Maniscalco M, Ambrosino P, Poto R, et al. Can FeNO be a biomarker in the post-COVID-19 patients monitoring? Respir Med. 2022;193:106745.","DOI":"10.1016\/j.rmed.2022.106745"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Gadish T, Soferman R, Merimovitch T, et al. Exhaled nitric oxide in acute respiratory syncytial virus bronchiolitis. Arch Pediatr Adolesc Med. 2010;164:727-731.","DOI":"10.1001\/archpediatrics.2010.128"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Antus B, Csiszer E, Czebe K, et al. Pulmonary infections increase exhaled nitric oxide in lung transplant recipients: a longitudinal study. Clin Transplant. 2005;19:377-382.","DOI":"10.1111\/j.1399-0012.2005.00354.x"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. T\u00fct\u00fcnc\u00fc EE, Gurbuz Y, Ozturk B, et al. Serum nitric oxide levels in patients with Crimean-Congo haemorrhagic fever. Scand J Infect Dis. 2010;42:385-388.","DOI":"10.3109\/00365540903501624"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Bingisser RM, Tilbrook PA, Holt PG, et al. Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3\/STAT5 signaling pathway. J Immunol. 1998;160:5729-5734.","DOI":"10.4049\/jimmunol.160.12.5729"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Niedbala W, Wei X-Q, Campbell C, et al. Nitric oxide preferentially induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor \u03b22 expression via cGMP. Proc Natl Acad Sci U S A. 2002;99:16186-16191.","DOI":"10.1073\/pnas.252464599"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Vos TA, Gouw A, Klok PA, et al. Differential effects of nitric oxide synthase inhibitors on endotoxin-induced liver damage in rats. Gastroenterology. 1997;113:1323-1333.","DOI":"10.1053\/gast.1997.v113.pm9322528"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Kubes P, McCafferty DM. Nitric oxide and intestinal inflammation. Am J Med. 2000;109:150-158.","DOI":"10.1016\/S0002-9343(00)00480-0"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/76\/4\/76_JJID.2022.470\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T04:17:00Z","timestamp":1690604220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/76\/4\/76_JJID.2022.470\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,31]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2022.470","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,31]]},"article-number":"JJID.2022.470"}}